Home | Support   Headline News: FDA Fake Drugs Drug Testing	TranS1 (TSON) Receives FDA Clearance to Market AxiaLIF 2L 28 Apr 08, 21:17 TranS1 Inc. (Nasdaq: TSON) has received 510(k) clearance from the US Food and Drug Administration (FDA) to market its AxiaLIF 2L, two level percutaneous ... more

© 2007 nafdacnigeria.org